Harrow Inc (HROW)
17.97
+0.03
(+0.17%)
USD |
NASDAQ |
Jun 14, 16:00
17.98
+0.01
(+0.06%)
After-Hours: 20:00
Harrow Free Cash Flow: -14.27M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -14.27M |
| December 31, 2023 | -148.71M |
| September 30, 2023 | -166.95M |
| June 30, 2023 | -147.09M |
| March 31, 2023 | -145.81M |
| December 31, 2022 | -6.068M |
| September 30, 2022 | -24.60M |
| June 30, 2022 | -25.54M |
| March 31, 2022 | -25.86M |
| December 31, 2021 | -23.43M |
| September 30, 2021 | 4.179M |
| June 30, 2021 | 8.983M |
| March 31, 2021 | 1.713M |
| December 31, 2020 | -2.094M |
| September 30, 2020 | -0.742M |
| June 30, 2020 | -3.281M |
| March 31, 2020 | 0.094M |
| December 31, 2019 | -0.887M |
| September 30, 2019 | -2.458M |
| June 30, 2019 | -2.629M |
| March 31, 2019 | -2.087M |
| December 31, 2018 | -1.516M |
| September 30, 2018 | -1.174M |
| June 30, 2018 | -3.381M |
| March 31, 2018 | -6.914M |
| Date | Value |
|---|---|
| December 31, 2017 | -9.877M |
| September 30, 2017 | -11.98M |
| June 30, 2017 | -14.21M |
| March 31, 2017 | -17.83M |
| December 31, 2016 | -18.35M |
| September 30, 2016 | -19.35M |
| June 30, 2016 | -17.62M |
| March 31, 2016 | -14.74M |
| December 31, 2015 | -12.32M |
| September 30, 2015 | -10.81M |
| June 30, 2015 | -9.662M |
| March 31, 2015 | -7.848M |
| December 31, 2014 | -7.231M |
| September 30, 2014 | -6.344M |
| June 30, 2014 | -5.615M |
| March 31, 2014 | -5.086M |
| December 31, 2013 | -4.459M |
| September 30, 2013 | -3.824M |
| June 30, 2013 | -3.352M |
| March 31, 2013 | -2.626M |
| December 31, 2012 | -1.916M |
| September 30, 2012 | -1.277M |
| June 30, 2012 | -0.638M |
| March 31, 2012 | -0.42M |
| December 31, 2011 | -0.2912M |
Free Cash Flow Range, Past 5 Years
-166.95M
Minimum
Sep 2023
8.983M
Maximum
Jun 2021
-36.27M
Average
-4.674M
Median
Free Cash Flow Benchmarks
| Durect Corp | -31.92M |
| Aquestive Therapeutics Inc | -26.60M |
| Cyclacel Pharmaceuticals Inc | -9.734M |
| Stereotaxis Inc | -8.683M |
| Cara Therapeutics Inc | -91.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.628M |
| Cash from Investing (Quarterly) | -0.11M |
| Cash from Financing (Quarterly) | -0.809M |
| Free Cash Flow Per Share (Quarterly) | -0.1336 |
| Free Cash Flow to Equity (Quarterly) | -5.714M |
| Free Cash Flow to Firm (Quarterly) | 0.677M |
| Free Cash Flow Yield | -2.34% |